VFSS Pro Mobile Digital Imaging System
Device Facts
| Record ID | K212523 |
|---|---|
| Device Name | VFSS Pro Mobile Digital Imaging System |
| Applicant | Imagexray, LLC |
| Product Code | OWB · Radiology |
| Decision Date | Nov 5, 2021 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 892.1650 |
| Device Class | Class 2 |
| Attributes | Pediatric |
Indications for Use
The VFSS Pro™ Mobile system is intended for use by a qualified/trained medical professionals, who have full understanding of the safety information and emergency procedures as well as the capabilities and functions of the device. The device provides fluoroscopic imaging and is used for guidance and visualization during routine fluoroscopic and image-guided procedures. The device is to be used in professional healthcare facilities, in a variety of image-guided procedures such as feeding tube and catheter insertion on pediatric patients except neonates (birth to one month). This device is not indicated for large/obese patients or interventional use. Applications can be performed with the patient sitting, standing, or lying in the prone or supine position. The system is not intended for mammography applications.
Device Story
Mobile fluoroscopic imaging system; utilizes low-powered mono-block generator and dynamic flat-panel detector (dFPD); powered via 120VAC outlet. Captures, processes, and displays high-definition fluoroscopic images up to 30 fps. Operated by trained medical professionals in healthcare facilities. Input: X-ray radiation; Output: real-time fluoroscopic images on workstation monitors. Enhancements include window/level adjustment, inversion, noise reduction, zoom, and pan. Images stored locally or sent via network for long-term storage/printing. Facilitates guidance during routine procedures like feeding tube/catheter insertion. Benefits include improved visualization of diagnostic areas; supports clinical decision-making through real-time image guidance.
Clinical Evidence
No clinical data. Bench testing only. Phantom images acquired and compared to predicate to assess imaging performance. System passed electrical, mechanical, and radiation safety testing (IEC 60601-1-3, IEC 60601-2-54, 21 CFR 1020.32).
Technological Characteristics
Mobile fluoroscopic system; 120VAC power. Components: mono-block generator, dynamic flat-panel detector (Vieworks FXDD-1212G amorphous Si or Rayence 1212FCA Indium Zinc Gallium Oxide), monitors, image processor PC. Connectivity: DICOM network. Software: Insight Agile DRF. Standards: IEC 60601-1, IEC 60601-1-2, IEC 60601-1-3, IEC 60601-2-54.
Indications for Use
Indicated for pediatric patients (excluding neonates birth to one month) for routine fluoroscopic and image-guided procedures, including feeding tube and catheter insertion. Not indicated for large/obese patients or interventional use. Intended for use by qualified/trained medical professionals in healthcare facilities.
Regulatory Classification
Identification
An image-intensified fluoroscopic x-ray system is a device intended to visualize anatomical structures by converting a pattern of x-radiation into a visible image through electronic amplification. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.
Special Controls
*Classification.* Class II (special controls). An anthrogram tray or radiology dental tray intended for use with an image-intensified fluoroscopic x-ray system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9. In addition, when intended as an accessory to the device described in paragraph (a) of this section, the fluoroscopic compression device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
Predicate Devices
- Virtual C DRF Digital Imaging System (K211191)
Reference Devices
- Insight Agile DRF Digital Imaging System (K210469)
- Vieworks FXDD-1212G (K200396)
- Rayence 1212FCA (K202722)
Submission Summary (Full Text)
{0}------------------------------------------------
November 5, 2021
Image /page/0/Picture/1 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: a symbol on the left and the FDA acronym with the full name of the agency on the right. The symbol on the left is a stylized representation of a human figure, while the FDA acronym is in a blue square. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.
IMAGExRAY, LLC % Mr. Daniel Kamm Principal Engineer Kamm & Associates 8870 Ravello Ct NAPLES FL 34114
Re: K212523
Trade/Device Name: VFSS Pro Mobile Digital Imaging System Regulation Number: 21 CFR 892.1650 Regulation Name: Image-intensified fluoroscopic x-ray system Regulatory Class: Class II Product Code: OWB, JAA, OXO, RCC, QHY Dated: August 9, 2021 Received: August 11, 2021
Dear Mr. Kamm:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
{1}------------------------------------------------
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801 and Part 809); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
, for
Thalia T. Mills, Ph.D. Director Division of Radiological Health OHT7: Office of In Vitro Diagnostics and Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
# Indications for Use
510(k) Number (if known) K212523
Device Name VFSS Pro Mobile Digital Imaging System
### Indications for Use (Describe)
The VFSS Pro Mobile system is intended for use by a qualified/trained medical professionals, who have full understanding of the safety information and emergency procedures as well of capabilities and function of the device. The device provides fluoroscopic imaging and is used for guidance and visualization during diagnostic radiographic, surgery, and interventional procedures. The device is to be used in healthcare facilities both inside of hospital, in a variety of procedures of the skull, spinal column, chest, abdomen, extremities, and at the medical professional the device may be used for other imaging applications on all patients except neonates (birth to one month) within the limits of the device. Applications can be performed with the patient sitting, standing, or lying in the prone or supine position. The system is not intended for mammography applications
Type of Use (Select one or both, as applicable)
| <span></span> | Prescription Use (Part 21 CFR 801 Subpart D) |
|---------------|----------------------------------------------|
| <span></span> | Over-The-Counter Use (21 CFR 801 Subpart C) |
### CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
## 510(k) Summary K212523 IMAGExRAY, LLC 160 Park Avenue Nutley, NJ 07110 USA Date Prepared: September 15, 2021 Prepared by: Gary Korkola Tel. 973-235-0606 Fax. 973-235-0132
This summary of 510(k) safety and effectiveness information is being submitted in accordance with requirements of 21 CFR Part 807.92.
- 1. Trade/proprietary name: VFSS Pro Mobile Digital Imaging System Regulation Name: Image-Intensified Fluoroscopic X-ray System Regulation Number: 21 CFR 892.1650 Regulatory Class: Class II OWB, JAA, OXO, RCC and QHY Product Code: Common/Usual Name: Mobile Fluoroscopic System
| 2. Predicate Device: | K211191 |
|------------------------|--------------------------------------|
| Trade Name: | Virtual C DRF Digital Imaging System |
| Manufacturer: | PortaVision Medical, LLC |
| Regulation Number: | 21 CFR 892.1650 |
| Regulatory Class: | Class II |
| Product Code: | OWB, JAA and OXO |
| Common/Usual Name: | Mobile Fluoroscopic System |
3. Reference Devices: (Used with this device)
| Imaging Chain: | |
|-----------------------|---------------------------------------------|
| Trade Name: | Insight Agile DRF Digital Imaging System |
| Manufacturer | Imaging Engineering, LLC |
| 510(k) Clearance #: | K210469 |
| Classification Name: | Image Intensified Fluoroscopic X-ray System |
| Classification Panel: | Radiology |
| CFR Section: | 21CFR 892.1650 |
| Product Codes: | JAA, OXO, RCC and QHY |
| Device Class: | Class II |
| Digital Panel(s) | (Customer picks one) |
|-----------------------|------------------------------------|
| Manufacturer: | Vieworks Co. LTD |
| Trade Name: | FXDD-1212G |
| 510(k) Clearance #: | K200396 |
| Classification Name: | Stationary x-ray system |
| Classification Panel: | Radiology |
| CFR Section: | 21CFR 892.1680 (Product Code: JAA) |
| Device Class: | Class II |
| OR | |
| Manufacturer: | Rayence Co. LTD |
| Trade Name: | 1212FCA |
| 510(k) Clearance #: | K202722 |
| Classification Name: | Stationary x-ray system |
| Classification Panel: | Radiology |
{4}------------------------------------------------
| CFR Section: | 21CFR 892.1680 (Product Code: MQB) |
|---------------|------------------------------------|
| Device Class: | Class II |
#### 4. Device Description
The VFSS Pro Mobile system is a mobile imaging system that can acquire, process, and display fluoroscopic images. It can be easily positioned within a room and moved from room within a facility. To provide the ability to perform fluoroscopic examinations as needed within a facility. The system employs a low-powered mono-block generator and a dynamic flat-panel detector so that it can be powered through a single-phase 120VAC power outlet. The imaging chain is powered by the Insight Agile DRF Digital Imaging System which allows the operator to view and enhance high-definition fluoroscopy images up to 30 fps. Images may be viewed and enhanced enabling the operator to bring out diagnostic difficult or impossible to see using conventional imaging techniques. Images can be stored locally for short term storage. The Insight Agile DRF Digital Imaging System enables the operator to produce hardcopy images with a laser printer or send images over a network for longer-term storage. The major system components include: a dynamic flat panel detector, monitors, and an image processor PC. This device employs either the Vieworks FXDD-1212G or the Rayence 1212FCA digital x-ray receptor panels (previously cleared, see Reference devices). The device software employed is from the Reference device Insight Agile DRF.
#### 5. Indications for Use
The VFSS Pro™ Mobile system is intended for use by a qualified/trained medical professionals, who have full understanding of the safety information and emergency procedures as well as the capabilities and functions of the device. The device provides fluoroscopic imaging and is used for guidance and visualization during routine fluoroscopic and image-guided procedures. The device is to be used in professional healthcare facilities, in a variety of image-guided procedures such as feeding tube and catheter insertion on pediatric patients except neonates (birth to one month). This device is not indicated for large/obese patients or interventional use. Applications can be performed with the patient sitting, standing, or lying in the prone or supine position. The system is not intended for mammography applications.
#### 6. Summary of Design Control Risk Management
The VFSS Pro Mobile DRF Digital Imaging System has been developed to professionals optimized workflow when imaging patients while meeting critical functional requirements and international safety standards. The risks and the hazardous impact of the device design were analyzed with FMEA method. The specific risk control and protective measures to mitigate the risks from the device design and production phase were reviewed and implemented in the new product design phase. The overall assessment concluded that all risks and hazardous conditions identified arising from the design and production were successfully mitigated and accepted.
### 7. Substantial Equivalence
The VFSS Pro Mobile Digital Imaging System conforms to the FDA recognized standards as like the predicate device. Based on the recognized standard conformity evidence related to the electro- mechanical, software-, clinical-and risk management, it's the sponsor's opinion that the subject device is a safe and effective device. Equivalence is evaluated in the comparison table below:
{5}------------------------------------------------
| Characteristic | PortaVision Medical, LLC<br>Virtual C DRF Digital Imaging<br>System (K211191) | VFSS Pro Mobile DRF Digital<br>Imaging System |
|--------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications for Use: | Intended for use by a qualified/trained<br>medical professionals, who have full<br>understanding of the safety information and<br>emergency procedures as well of capabilities<br>and function of the device. The device<br>provides fluoroscopic imaging and is used for<br>guidance and visualization during diagnostic<br>radiographic, surgery, and interventional<br>procedures. The device is to be used in<br>healthcare facilities both inside and outside of<br>hospital, in a variety of procedures of the<br>skull, spinal column, chest, abdomen,<br>extremities, and at the discretion of the<br>medical professional the device may be used<br>for other imaging applications on all patients<br>except neonates (birth to one month) within<br>the limits of the device. Applications can be<br>performed with the patient sitting, standing,<br>or lying in the prone or supine position. The<br>system is not intended for mammography<br>applications. | The VFSS Pro™ Mobile system is intended for<br>use by a qualified/trained medical<br>professionals, who have full understanding of<br>the safety information and emergency<br>procedures as well as the capabilities and<br>functions of the device. The device provides<br>fluoroscopic imaging and is used for guidance<br>and visualization during routine fluoroscopic<br>and image-guided procedures. The device is<br>to be used in professional healthcare<br>facilities, in a variety of image-guided<br>procedures such as feeding tube and catheter<br>insertion on pediatric patients except<br>neonates (birth to one month). This device is<br>not indicated for large/obese patients or<br>interventional use. Applications can be<br>performed with the patient sitting, standing,<br>or lying in the prone or supine position. The<br>system is not intended for mammography<br>applications.<br>Comparison note: This indication is a<br>specialized subset of the capabilities of the<br>predicate and excludes interventional<br>procedures. |
| Power source | 120 VAC 50/60 Hz 2.5 amps | 120 VAC 50/60 Hz 2.5 amps |
| System Weight<br>and Size | 121 lbs. 36″ x 26″ x 77″ | 410 lbs. 78.4" x 40" x 84.85" |
| Generator Type | High frequency inverter type Source Ray | SAME |
| Output Power | 80 kVp x 2 ma = 160 watts for Source Ray<br>Generator | 80 kVp x 1 ma = 80 watts Similar power<br>level. Different model of the SAME generator |
| Fluoroscopy | .001 - 2 mA, 35 - 80 kV | 0.001 – 1 mA (Cont.) 35 – 80 kV |
| Image acquisition | 1 – 15 fps DRTECH Detectors<br>1 - 30 fps Vieworks Detectors | Up to 30 fps |
| X-ray Tube | Stationary Anode | SAME |
| Indicators | Display on workstation monitor | SAME |
| Collimator | Machine Vision motorized made by<br>PortaVision, model MVC | Fixed Aperture with 0.1 mm Cu fixed filter |
| Digital Panel<br>Specification | Vivix-D1212G, Vivix-D1717G or<br>EVS 4343WP or EVS 3643WP | Vieworks 1212G or<br>Rayence 1212FCA |
| Pixel Pitch | 140 or 145 μm | Vieworks 1212G 145 µm<br>Rayence 1212FCA 194 µm |
| Characteristic | PortaVision Medical, LLC<br>Virtual C DRF Digital Imaging<br>System (K211191) | VFSS Pro Mobile DRF Digital<br>Imaging System |
| Pixel Matrix | 2048 x 2048 | Vieworks 2000 x 2000<br>Rayence 1536 x 1536 (K210469) |
| Panel Sizes | 17 x 17, 14 x 17, 12 x 12 | 12 x 12 |
| A/D conversion | 16 bits | SAME |
| Performance<br>Standard | 21 CFR 1202.30 | SAME |
| Electrical Safety | IEC60601-1:2005 + A1 (2012)<br>IEC60601-1-2:2007<br>IEC60601-1-3:2008<br>IEC60601-2-28:2010<br>IEC60601-2-43:2010<br>IEC60601-2-54:2009<br>NEMA PS 3.1-3.20 | IEC60601-1:2005 + A1 (2012)<br>IEC60601-1-2:2014+ANSI+AAMI<br>IEC60601-1-3:2008+A1:2013<br>IEC60601-2-54:2009 +AMD1:2015 +AMD2:2018<br>NEMA PS 3.1-3.20 |
| Photo | Image: PortaVision Medical, LLC Virtual C DRF Digital Imaging System | Image: VFSS Pro Mobile DRF Digital Imaging System |
{6}------------------------------------------------
The following table compares The MobileRay Pulse SE software (predicate device) to the subject device software.
| Feature | Virtual C DRF Digital Imaging<br>System (K211191) | Subject Device |
|-------------------------------|---------------------------------------------------|----------------|
| Acquiring image from detector | Yes | Yes |
| Viewing image | Yes | Yes |
| Change window/level | Yes | Yes |
| Invert | Yes | Yes |
| Lookup Table | Yes | Yes |
| Zoom | Yes | Yes |
| Pan | Yes | Yes |
| Noise Reduction | Yes | Yes |
| Patient Information | Yes | Yes |
| Annotation | Yes | Yes |
| Image rotation | Yes | Yes |
{7}------------------------------------------------
| Feature | Virtual C DRF Digital Imaging<br>System (K211191) | Subject Device |
|-------------------------|---------------------------------------------------|----------------|
| X-Ray generator control | Yes | Yes |
| DICOM worklist and Send | Yes | Yes |
## Difference Discussion
The subject device has similar indications for use and similar technological characteristics as the predicate device. The software application and the Vieworks and Rayence flat panel detectors have already been cleared as fluoroscopic imaging chain components (K210469). The primary differences are that a lower powered x-ray generator is used (80 vs 160 watts) and that the predicate device is a portable system whereas the subject device is a mobile system. The subject device represents a subset of the predicate for the purpose of specialization of the particular procedures that can be performed, namely Video Fluoroscopic Swallow Studies and similar studies.
## 8. Summary of the technological characteristics of the device compared to the predicate device
Two dFPD detectors are being applied for clearance in this application. One of the dFPDs is manufactured by Vieworks and was cleared previously with Insight Enhanced (K200396) and uses the same manufacturing technology (amorphous Si) as the dFPD on the predicate device. The second dFPD is manufactured by Rayence (1212FCA), this detector is based on 3ª generation flat panel television technology (Indium Zinc Gallium Oxide or IZGO). This technology provides a lower noise floor and much longer detector lifetime compared with a-Si based dFPDs due to its ten-fold increase in radiation damage resistance. The Rayence 1212FCA was recently cleared with Insight Agile DRF (K210469).
## 9. Description of non-clinical tests.
Bench testing was performed on the subject device with the Rayence 1212FCA on the system to assess substantial equivalence compared to the predicate device. Both detectors were integrated with the Source-Ray generator. Phantom images were acquired with the subject device and compared to the predicate device. These images and the doses used to acquire them were analyzed and compared. In conclusion, the tests obtained demonstrated substantial equivalence to the predicate device in terms of imaging performance.
Additional bench testing was performed by Imaging Engineering on the VFSS Pro Mobile system to determine if the system complies with IEC 60601-1-3, IEC60601-2-54 and 21 CFR 1020.32. The system passed all electrical, mechanical and radiation safety testing. EMC and Electrical Safety performance for the Rayence digital receptor panel had previously been submitted to FDA in K202722.
Software has been written and validated according to the FDA Software Guidance: Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices Document issued on: May 11, 2005. Cybersecurity concerns have been addressed in accordance with: Content of Premarket Submissions for Management of Cybersecurity in Medical Devices Guidance for Industry and Food and Drug Administration Staff (October 2, 2014).
- 10. Description of clinical tests. No clinical data is necessary to evaluate safety or effectiveness for purposes of determining substantial equivalence of the proposed modification. Bench testing was performed to assess the device safety and effectiveness.
### 11. Conclusion as to Substantial Equivalence.
The VFSS Pro Mobile Digital Imaging System, the subject device is substantially equivalent to the predicate (K21191). The intended use, the design principle, and the applicable standards for the subject device are similar to those of the predicate device. The performance test and non-clinical consideration result demonstrate that these differences do not raise any new questions of safety and effectiveness. Therefore, it is the sponsor's opinion that the subject device appears to be as safe and effective as the predicate device.
